Cargando…
Oxido[2-{(E)-[((1E)-{(E)-2-[1-(2-oxidophenyl)ethylidene]hydrazin-1-ylidene}(prop-2-en-1-ylsulfanyl)methyl)imino]methyl}phenolato]vanadium(IV)
The V(IV) atom in the title complex, [V(C(19)H(17)N(3)O(2)S)O], is coordinated by two N and two O atoms of the dianionic tetradentate Schiff base ligand and the terminal oxide O atom. The N(2)O(3) donor set defines a square-pyramidal coordination geometry with the oxide O atom in the apical site. S...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Union of Crystallography
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3414106/ https://www.ncbi.nlm.nih.gov/pubmed/22904713 http://dx.doi.org/10.1107/S1600536812029819 |
_version_ | 1782240152344592384 |
---|---|
author | Takjoo, Reza Ng, Seik Weng Tiekink, Edward R. T. |
author_facet | Takjoo, Reza Ng, Seik Weng Tiekink, Edward R. T. |
author_sort | Takjoo, Reza |
collection | PubMed |
description | The V(IV) atom in the title complex, [V(C(19)H(17)N(3)O(2)S)O], is coordinated by two N and two O atoms of the dianionic tetradentate Schiff base ligand and the terminal oxide O atom. The N(2)O(3) donor set defines a square-pyramidal coordination geometry with the oxide O atom in the apical site. Some buckling in the tetradentate ligand is indicated by the dihedral angle of 17.92 (19)° between the six-membered chelate rings. Supramolecular chains are formed along the b axis via C—H⋯O contacts in the crystal. The chains are connected into a layer in the ab plane via C—H⋯π interactions. The atoms comprising the –SCH(2)—CH=CH(2) and methyl substituents were found to be disordered in a 0.916 (2):0.088 (2) ratio. The crystal studied was found to be twinned by nonmerohedry with a 28.1 (4)% minor twin component. |
format | Online Article Text |
id | pubmed-3414106 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | International Union of Crystallography |
record_format | MEDLINE/PubMed |
spelling | pubmed-34141062012-08-17 Oxido[2-{(E)-[((1E)-{(E)-2-[1-(2-oxidophenyl)ethylidene]hydrazin-1-ylidene}(prop-2-en-1-ylsulfanyl)methyl)imino]methyl}phenolato]vanadium(IV) Takjoo, Reza Ng, Seik Weng Tiekink, Edward R. T. Acta Crystallogr Sect E Struct Rep Online Metal-Organic Papers The V(IV) atom in the title complex, [V(C(19)H(17)N(3)O(2)S)O], is coordinated by two N and two O atoms of the dianionic tetradentate Schiff base ligand and the terminal oxide O atom. The N(2)O(3) donor set defines a square-pyramidal coordination geometry with the oxide O atom in the apical site. Some buckling in the tetradentate ligand is indicated by the dihedral angle of 17.92 (19)° between the six-membered chelate rings. Supramolecular chains are formed along the b axis via C—H⋯O contacts in the crystal. The chains are connected into a layer in the ab plane via C—H⋯π interactions. The atoms comprising the –SCH(2)—CH=CH(2) and methyl substituents were found to be disordered in a 0.916 (2):0.088 (2) ratio. The crystal studied was found to be twinned by nonmerohedry with a 28.1 (4)% minor twin component. International Union of Crystallography 2012-07-07 /pmc/articles/PMC3414106/ /pubmed/22904713 http://dx.doi.org/10.1107/S1600536812029819 Text en © Takjoo et al. 2012 http://creativecommons.org/licenses/by/2.0/uk/ This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited. |
spellingShingle | Metal-Organic Papers Takjoo, Reza Ng, Seik Weng Tiekink, Edward R. T. Oxido[2-{(E)-[((1E)-{(E)-2-[1-(2-oxidophenyl)ethylidene]hydrazin-1-ylidene}(prop-2-en-1-ylsulfanyl)methyl)imino]methyl}phenolato]vanadium(IV) |
title | Oxido[2-{(E)-[((1E)-{(E)-2-[1-(2-oxidophenyl)ethylidene]hydrazin-1-ylidene}(prop-2-en-1-ylsulfanyl)methyl)imino]methyl}phenolato]vanadium(IV) |
title_full | Oxido[2-{(E)-[((1E)-{(E)-2-[1-(2-oxidophenyl)ethylidene]hydrazin-1-ylidene}(prop-2-en-1-ylsulfanyl)methyl)imino]methyl}phenolato]vanadium(IV) |
title_fullStr | Oxido[2-{(E)-[((1E)-{(E)-2-[1-(2-oxidophenyl)ethylidene]hydrazin-1-ylidene}(prop-2-en-1-ylsulfanyl)methyl)imino]methyl}phenolato]vanadium(IV) |
title_full_unstemmed | Oxido[2-{(E)-[((1E)-{(E)-2-[1-(2-oxidophenyl)ethylidene]hydrazin-1-ylidene}(prop-2-en-1-ylsulfanyl)methyl)imino]methyl}phenolato]vanadium(IV) |
title_short | Oxido[2-{(E)-[((1E)-{(E)-2-[1-(2-oxidophenyl)ethylidene]hydrazin-1-ylidene}(prop-2-en-1-ylsulfanyl)methyl)imino]methyl}phenolato]vanadium(IV) |
title_sort | oxido[2-{(e)-[((1e)-{(e)-2-[1-(2-oxidophenyl)ethylidene]hydrazin-1-ylidene}(prop-2-en-1-ylsulfanyl)methyl)imino]methyl}phenolato]vanadium(iv) |
topic | Metal-Organic Papers |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3414106/ https://www.ncbi.nlm.nih.gov/pubmed/22904713 http://dx.doi.org/10.1107/S1600536812029819 |
work_keys_str_mv | AT takjooreza oxido2e1ee212oxidophenylethylidenehydrazin1ylideneprop2en1ylsulfanylmethyliminomethylphenolatovanadiumiv AT ngseikweng oxido2e1ee212oxidophenylethylidenehydrazin1ylideneprop2en1ylsulfanylmethyliminomethylphenolatovanadiumiv AT tiekinkedwardrt oxido2e1ee212oxidophenylethylidenehydrazin1ylideneprop2en1ylsulfanylmethyliminomethylphenolatovanadiumiv |